Clinuvel Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Clinuvel Pharmaceuticals is a dividend paying company with a current yield of 0.38%.
Key information
0.4%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 0.5% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 24.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.0339 |
| Payout ratio | 7% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: UR9A is not paying a notable dividend for the German market, therefore no need to check if payments are stable.
Growing Dividend: UR9A is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Clinuvel Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (UR9A) | 0.4% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (UR9A) (up to 3 years) | 0.9% |
Notable Dividend: UR9A's dividend (0.38%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.69%).
High Dividend: UR9A's dividend (0.38%) is low compared to the top 25% of dividend payers in the German market (4.76%).
Earnings Payout to Shareholders
Earnings Coverage: UR9A is not paying a notable dividend for the German market.
Cash Payout to Shareholders
Cash Flow Coverage: UR9A is not paying a notable dividend for the German market.